Patent · US Active

Nano-scale contrast agents and methods of use

US8642013B2 · kind B2 · utility

5Cited by

22References

21Claims

0Family size

Inventors

Ananth Annapragada · Manvel, US
Ravi V. Bellamkonda · Atlanta, US
Efstathios Karathanasis · Atlanta, US
Russell M. Lebovitz · San Diego, US

Key dates

Filing date	Dec 5, 2008
Grant date	Feb 4, 2014
Priority date	—
Expiry date	Apr 4, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions and methods are disclosed for evaluating a subject's vasculature integrity, for differentiating between a malignant lesion and a benign lesion, for evaluating the accessibility of a tumor to nano-sized therapeutics, for treating tumors, and for live or real time monitoring of a nano-probe's biodistribution.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.